Trade Agreement: Canadian Free Trade Agreement (CFTA)
Tendering Procedures: All interested suppliers may submit a bid
Competitive Procurement Strategy: Lowest/Lower Bid
Comprehensive Land Claim Agreement: No
Nature of Requirements:
Requirement
To supply Meningococcal C and/or Quadrivalent vaccines on as and when requested basis to various Federal, Provincial and Territorial (F/P/T) governments as part of the F/P/T Group Purchasing Program.
Quantity
Meningococcal C Vaccine
The estimated requirement is 433,704 for firm year 20120-21.
Contract Period
April 1, 2020 to March 31, 2021 with the option to extend the contract period for two additional one year periods from April 1, 2021 to March 31, 2022 and April 1, 2022 to March 31, 2023.
Meningococcal Quadrivalent Vaccine
The estimated requirement is 390,365 for for firm year 2020-21.
Contract Period
April 1, 2020 to March 31, 2021 with the option to extend the contract period for two additional one year periods from April 1, 2021 to March 31, 2022 and April 1, 2022 to March 31, 2023.
Delivery
Will be on as and when requested basis.
This requirement is for the Federal/Provincial/Territorial(F/P/T) Group
Purchasing Program for Drugs and Vaccines. Canada is acting as a purchasing agent for Provincial and Territorial Governments.
Inquiries regarding this RFP are to be submitted to the contracting officer listed below.
Delivery Date: 16/12/2019
The Crown retains the right to negotiate with suppliers on any procurement.
Documents may be submitted in either official language of Canada.
